SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments

文献类型： 外文期刊

第一作者： Zhang, Xirui

作者： Zhang, Xirui;Yuan, Hao;Yang, Zipeng;Hu, Xiaoyu;Zhu, Xiaojing;Zhang, Xiu-Xiang;Yuan, Zi-Guo;Yang, Zipeng;Luo, Shengjun;Wang, Xiao-Hu;Zheng, Chunfu;Mahmmod, Yasser S.;Mahmmod, Yasser S.;Zhao, Cuiping;Zhai, Jingbo;Xue, Mengzhou;Zheng, Chunfu

作者机构：

关键词： SARS-CoV-2; COVID-19; evolution; vaccines; drug; treatments

期刊名称：VACCINES （ 影响因子：4.961； 五年影响因子：5.325 ）

ISSN：

年卷期： 2022 年 10 卷 12 期

页码：

收录情况： SCI

摘要： Since the SARS-CoV-2 outbreak, pharmaceutical companies and researchers worldwide have worked hard to develop vaccines and drugs to end the SARS-CoV-2 pandemic. The potential pathogen responsible for Coronavirus Disease 2019 (COVID-19), SARS-CoV-2, belongs to a novel lineage of beta coronaviruses in the subgenus arbovirus. Antiviral drugs, convalescent plasma, monoclonal antibodies, and vaccines are effective treatments for SARS-CoV-2 and are beneficial in preventing infection. Numerous studies have already been conducted using the genome sequence of SARS-CoV-2 in comparison with that of other SARS-like viruses, and numerous treatments/prevention measures are currently undergoing or have already undergone clinical trials. We summarize these studies in depth in the hopes of highlighting some key details that will help us to better understand the viral origin, epidemiology, and treatments of the virus.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序